Regulation of TNF-&alpha expression by serum amyloid A and the effect on renal glomerular cells in diabetic nephropathy patients

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Biomedical Research-tokyo

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4066/BIOMEDICALRESEARCH.29-17-3170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The Involvement of Serum Amyloid A in Psoriatic Inflammation.

  2017cited by this paper
• Acute‐phase protein serum amyloid A3 is a novel paracrine coupling factor that controls bone homeostasis

  2015cited by this paper
• Management of diabetic nephropathy: Recent progress and future perspective.

  2015cited by this paper
• Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes

  2015cited by this paper
• Serum Amyloid A Facilitates Early Lesion Development in Ldlr−/− Mice

  2015cited by this paper
• Improved prognosis of diabetic nephropathy in type 1 diabetes.

  2015cited by this paper
• Serum amyloid A and inflammation in diabetic kidney disease and podocytes

  2014cited by this paper
• Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice.

  2014cited by this paper
• Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients.

  2013cited by this paper
• High-Density Lipoproteins Inhibit Vascular Endothelial Inflammation by Increasing 3&bgr;-Hydroxysteroid-&Dgr;24 Reductase Expression and Inducing Heme Oxygenase-1

  2013cited by this paper
• Acute-Phase Serum Amyloid A Protein and Its Implication in the Development of Type 2 Diabetes in the KORA S4/F4 Study

  2013cited by this paper
• The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A

  2013cited by this paper
• Diabetic nephropathy: Cholesterol and podocyte injury

  2013cited by this paper
• Serum amyloid A stimulates macrophage foam cell formation via lectin-like oxidized low-density lipoprotein receptor 1 upregulation.

  2013cited by this paper
• Complexity of diabetic nephropathy pathogenesis and design of investigations

  2013cited by this paper
• Impact of serum amyloid A on cellular cholesterol efflux to serum in type 2 diabetes mellitus.

  2013cited by this paper
• Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss.

  2013cited by this paper
• New targets for treatment of diabetic nephropathy: what we have learned from animal models

  2012cited by this paper
• Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy

  2012cited by this paper
• Effects of Intensive Glucose Lowering in Type 2 Diabetes

  2009cited by this paper
• Inflammation and pathogenesis of diabetic nephropathy.

  2004cited by this paper
• Comparison of Diabetes Diagnostic Categories in the U.S. Population According to 1997 American Diabetes Association and 1980–1985 World Health Organization Diagnostic Criteria

  1997influential reference

• No citing papers are available for this paper.